Goodall-Witcher Healthcare logo

COVID Vaccine Booster Guidelines

Posted: Friday, October 22, 2021, 11:53 AM
Updated: Friday, October 22, 2021, 11:56 AM

The use of a single booster dose of the Moderna COVID-19 Vaccine that may be administered at least 6 months after completion of the primary series to individuals:

- 65 years of age and older

- 18 through 64 years of age at high risk of severe COVID-19

- 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2

The use of a single booster dose of the Janssen (Johnson and Johnson) COVID-19 Vaccine may be administered at least 2 months after completion of the single-dose primary regimen to individuals 18 years of age and older.

The use of each of the available COVID-19 vaccines as a heterologous (or “mix and match”) booster dose in eligible individuals following completion of primary vaccination with a different available COVID-19 vaccine.

To clarify that a single booster dose of the Pfizer-BioNTech COVID-19 Vaccine may be administered at least 6 months after completion of the primary series to individuals 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2.

<< Go Back